Whalegun
Home

Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Sell · Filed 25/04/21

Trade details

Type
Insider sale
Amount
$82,100
Shares · price
5,000 sh · $16.42 a share
Held after
985,392 sh
Stock
Enliven Therapeutics ELVN
Person
Samuel KintzPresident and CEO
Trade date
25/04/17
Filed
25/04/21
Days to filing
4 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/18~25/05/17

Samuel Kintz's recent trades

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/17

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.7M

    Filed 01/09

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.3M

    Filed 01/08

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $84.6K

    Filed 25/12/17

  • Samuel Kintz

    Sell10b5-1 planEnliven Therapeutics

    $272.8K

    Filed 25/11/19

Samuel Kintz, CEO — sold $82.1K of Enliven Therapeutics ELVN · 0.5% of holdings · 10b5-1 plan | Whalegun